The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.
Hazel R. Scott,Donald C. McMillan,L M Forrest,Duncan J.F Brown,Colin S. McArdle,Robert Milroy +5 more
Reads0
Chats0
TLDR
The results indicate that the majority of patients with inoperable non-small cell lung cancer have evidence of a systemic inflammatory response and an increase in the magnitude of the systemicinflammatory response resulted in greater weight loss, poorer performance status, more fatigue and poorer survival.Abstract:
The relationship between the magnitude of systemic inflammatory response and the nutritional/functional parameters in patients with inoperable non-small cell lung cancer were studied The extent of weight loss, albumin, C-reactive protein, performance status and quality of life was measured in 106 patients with inoperable non-small cell lung cancer (stages III and IV) Survival analysis was performed using the Cox proportional hazard model The majority of patients were male and almost 80% had elevated circulating C-reactive protein concentrations (>10 mg x l(-1)) On multivariate analysis, age (P=0012), tumour type (0002), weight loss (P=0056), C-reactive protein (P=0047), Karnofsky performance status (P=0002) and fatigue (P=0046) were independent predictors of survival The patients were grouped according to the magnitude of the C-reactive protein concentrations ( 100 mg x l(-1)) An increase in the magnitude of the systemic inflammatory response was associated with increased weight loss (P=0004), reduced albumin concentrations (P=0001), reduced performance status (P=0060), increased fatigue (P=0011) and reduced survival (HR 1936 95%CI 1414-2650, P<0001) These results indicate that the majority of patients with inoperable non-small cell lung cancer have evidence of a systemic inflammatory response Furthermore, an increase in the magnitude of the systemic inflammatory response resulted in greater weight loss, poorer performance status, more fatigue and poorer survivalread more
Citations
More filters
Prostaglandin E2 in Brain-mediated Illness Responses
TL;DR: The battle against threatening infectious agents includes activation of both the innate and of the adaptive immune systems, both of which are involved in the development of the immune system.
Journal ArticleDOI
Cancer-related inflammation as predicting tool for treatment outcome in locally advanced and metastatic non-small cell lung cancer.
Sonja Badovinac,Marta Korsic,Davorka Mursic,Miroslav Samarzija,Branka Cucevic,Mihovil Roglić,Marko Jakopović +6 more
TL;DR: The findings from this study support the growing evidence of inflammation and cancer relationship, where elevated pre-treatment level of CRP has negative predictive significance on the NSCLC frontline chemotherapy response.
Journal ArticleDOI
Efficacy of apatinib combined with FOLFIRI in the first-line treatment of patients with metastatic colorectal cancer
TL;DR: In this paper , the efficacy and safety of apatinib combined with FOLFIRI in the first-line treatment of advanced metastatic colorectal cancer (mCRC) and explore potential factors of efficacy.
Journal ArticleDOI
Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas.
Kunihiro Asanuma,Tomoki Nakamura,Yumiko Asanuma,Takuya Kakimoto,Yuki Yada,Tomohito Hagi,Kouji Kita,Akihiko Matsumine,Akihiro Sudo +8 more
TL;DR: It is demonstrated that a high level of soluble TM has the potential to be a significant predictor of metastasis and poor prognosis in STS patients.
Journal ArticleDOI
Molecular mechanisms of cancer cachexia‐related loss of skeletal muscle mass: data analysis from preclinical and clinical studies
TL;DR: In this paper , the authors provide an extensive and comparative analysis of the molecular mechanisms involved in the regulation of skeletal muscle mass in human cachectic cancer patients and in animal models of cancer cachexia.
References
More filters
Journal ArticleDOI
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
Neil K. Aaronson,Sam H Ahmedzai,Bengt Bergman,Monika Bullinger,Ann Cull,Nicole Duez,Antonio Filiberti,Henning Flechtner,Stewart B. Fleishman,Johanna C. J. M. de Haes,Stein Kaasa,M. Klee,David Osoba,Darius Razavi,Peter B. Rofe,Simon Schraub,Kommer C. A. Sneeuw,Marianne Sullivan,Fumikazu Takeda +18 more
TL;DR: The reliability and validity of the EORTC QLQ-C30 questionnaire were highly consistent across the three language-cultural groups studied: patients from English-speaking countries, Northern Europe, and Southern Europe.
Journal ArticleDOI
A new international staging system for lung cancer
TL;DR: The International Staging System for Lung Cancer provides for classification of six levels of disease extent in five stage groups that relate to patient management and prognosis and can be readily applied in a broad spectrum of clinical and teaching environments.
Journal ArticleDOI
The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting.
TL;DR: The utility of the Karnofsky Performance Status Scale as a valuable research tool when employed by trained observers is suggested and the relationship of the KPS to longevity in a population of terminal cancer patients documents its predictive validity.
Journal ArticleDOI
The new International Staging System for Lung Cancer.
TL;DR: The International Staging System for Lung Cancer provides for classification of six levels of disease extent in five stage groups that relate to patient management and prognosis and can be readily applied in a broad spectrum of clinical and teaching environments.
Journal ArticleDOI
Acute-phase protein response and survival duration of patients with pancreatic cancer.
J. S. Falconer,Kenneth C. H. Fearon,James A. Ross,R. Elton,Stephen J. Wigmore,O. J. Garden,David Carter +6 more
TL;DR: Whether certain nutritional indices and the acute‐phase protein response are prognostic factors independent of disease stage for patients with unresectable pancreatic cancer are determined.
Related Papers (5)
Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
Prognostic effect of weight loss prior tochemotherapy in cancer patients
William D. Dewys,Colin B. Begg,Philip T. Lavin,Pierre R. Band,John M. Bennett,Joseph R. Bertino,Martin H. Cohen,Harold O. Douglass,Paul F. Engstrom,Ediz Z. Ezdinli,John Horton,Gerhard J. Johnson,Charles G. Moertel,Martin M. Oken,Charles P. Perlia,Charles Rosenbaum,Murray N. Silverstein,Roland T. Skeel,Robert W. Sponzo,Douglass C. Tormey +19 more